Use of rFXIII in Treatment of Congenital FXIII Deficiency, a Prospective Multi-centre Observational Study

Clinical trial NCT01862367 · COMPLETED

Trial details

NCT number: NCT01862367
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Study type: OBSERVATIONAL

Congenital Bleeding Disorder Congenital FXIII Deficiency

Start date: 2013-05-17
Primary completion: 2019-06-26
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.